About Monroe Biomedical Research
Advancing your research with care, consistency, and purpose.
Monroe Biomedical Research (MBR) is a clinical research site organization conducting Phase 1–4 clinical trials across cardiometabolic, endocrinology, respiratory, general medicine, and other therapeutic areas.
When you work with MBR, you get the advantages of a fully owned research site network supported by centralized operations. Contracting, startup, regulatory, and participant recruitment are coordinated through a single point of contact, helping reduce complexity and keep studies moving.
For Sponsors and CROs, that means clearer communication, more consistent execution, and a more streamlined trial experience across sites. For participants, it means access to clinical research opportunities through teams who explain each step, answer questions, and provide a respectful, supportive experience.
Our Mission
Deliver exceptional research and great experiences for every participant and every partner, every time.
Care Deeply
Own Your Impact
Deliver Excellence
Enrich Your Community
Join Us
Help move medicine forward. MBR offers the chance to be part of a team built around care, accountability, excellence, and community impact.
Leadership
MBR’s leadership team brings experience across clinical research operations, finance, commercial strategy, participant recruitment, and site network growth. Their work gives Sponsors and CROs a more coordinated research partner and gives participants a trial experience grounded in care, quality, and respect.
Suvi Gross
Co-Founder and CEO
Suvi Gross is a co-founder and CEO of MBR, where she has led site operations and clinical research strategy since the company's founding. She has dedicated her career to advancing clinical research and improving outcomes for the people it serves.
As CEO, she leads a growing network of clinical research sites committed to delivering high-quality Phase 1–4 trials across a wide range of therapeutic areas. Under her leadership, MBR has built centralized operations infrastructure that gives Sponsors and CROs a single point of contact across sites, from contracting and startup through regulatory and participant recruitment. This drives a leaner, faster, more consistent trial experience.
Suvi's commitment to inclusive research runs through everything MBR does. She believes research should reflect the full range of people the medicines are meant to serve, and she has built MBR's enrollment strategy, site culture, and community relationships around that principle.
Her path to clinical research leadership started at the bedside. Before co-founding MBR, she worked as an EMT, an operating room assistant, and a research coordinator at UNC-Chapel Hill, including field research on gastric disease in rural Honduras. Suvi spent several years in site operations and pharmaceutical consulting before launching MBR in 2014 and has nearly 20 years of industry experience. She holds a BA in Biology from Princeton University.
Travis Milnes
Chief Financial Officer
Travis Milnes joined MBR as CFO in 2026, bringing deep experience in financial strategy, operations, and growth-stage leadership across the clinical research industry.
Before joining MBR, Travis served as CFO of Paradigm Clinical Research, where he held broad responsibility for corporate strategy, finance, tax, treasury, human resources, and contracts. Prior to that, he spent eight years as Vice President of Finance at Advarra, overseeing all financial operations and external reporting to a private equity board. During his tenure, he led financial diligence and accounting integration across 11 acquisitions and supported successful change-of-control transactions.
Earlier in his career, Travis managed audit and compliance engagements at SB & Company, where he worked across employee benefit plans, government, and nonprofit sectors.
Travis holds a BS in Accounting from the University of Baltimore, where he was a member of Beta Alpha Psi, the accounting and finance honors society.
Felicia Irvin
Chief Commercial Officer
As CCO of MBR, Felicia Irvin leads commercial strategy and business development. She brings more than 15 years of clinical research experience spanning business development, operations, patient recruitment, and network growth.
Felicia has built her career connecting strategy to execution. She brings a practical understanding of how commercial decisions shape site performance, startup timelines, and enrollment, and she uses that insight to build strong Sponsor and CRO relationships and growth plans grounded in operational reality. Before joining MBR, she held senior leadership roles at M3 Wake Research, Centricity Research, and IACT Health, where she led business development teams, expanded commercial partnerships, and supported growth across multi-site research networks.
Her experience in both commercial and operational leadership gives her a broad view of the clinical research ecosystem, from study opportunity and feasibility through site startup and participant enrollment. At MBR, she applies that experience to help align central oversight and commercial strategy across the site network.
Felicia holds a BA in Biology from William Woods University and an MBA from the University of Phoenix.
Deborah Tunick
Senior Vice President of Operations
New at MBR
-
MBR Welcomes Felicia Irvin as Chief Commercial Officer
We’re welcoming Felicia Irvin to MBR as Chief Commercial Officer. Felicia brings more than 15 years of experience in clinical research, with expertise spanning business development, operations, patient recruitment, and network growth. She has built her career by bridging commercial commitments with operational delivery. As CCO, she will lead MBR’s … Read more
-
Monroe Biomedical Research Acquires L-MARC to Expand Therapeutic Expertise and Geographic Footprint
Monroe Biomedical Research (MBR), a leading clinical trial site network specializing in patient recruitment for complex clinical trials, has completed the acquisition of L-MARC (Louisville Metabolic and Atherosclerosis Research Center, Inc.), a nationally recognized clinical research site based in Louisville, Kentucky. Founded by Dr. Harold Bays, L-MARC has built a strong reputation … Read more
-
Understanding and Managing Agitation in Alzheimer’s
Agitation in Alzheimer’s can signal discomfort, confusion, fear, pain, or an unmet need. Learn common triggers and practical caregiver strategies.
